Direct vs Indirect Revascularization in a North American Cohort of Moyamoya Disease

Pui Man Rosalind Lai1, Nirav J Patel1, Kai U Frerichs1

  • 1Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Neurosurgery
|May 6, 2021
PubMed
Abstract

Insights

Direct revascularization for moyamoya disease (MMD) showed fewer long-term ischemic and hemorrhagic events. While early complications and overall outcomes were similar, direct bypasses reduced combined events in this North American cohort.

Area of Science:

  • Neurosurgery
  • Neurology
  • Vascular Surgery

Background:

  • Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive stenosis of intracranial arteries.
  • The optimal surgical strategy for ischemic MMD, specifically direct versus indirect revascularization, is debated.
  • This study addresses the efficacy of these procedures in a North American adult cohort.

Purpose of the Study:

  • To compare the outcomes of direct versus indirect revascularization in adult patients with ischemic moyamoya disease.
  • To evaluate early postoperative complications, long-term ischemic events, and overall clinical outcomes.

Main Methods:

  • Retrospective review of adult MMD patients with ischemic presentation (1984-2018).
  • Inclusion of patients who underwent either direct or indirect bypass surgery.
  • Analysis of early and late outcomes using multivariable logistic and Cox proportional hazards regression models, performed per hemisphere.

Main Results:

  • Direct bypasses were associated with significantly fewer long-term ischemic and hemorrhagic events combined (adjusted HR 0.19, P=0.007).
  • No significant differences were observed in early surgical complications (3.5% vs 8.6%, P=0.24) or outcomes (mRS ≥3, P=0.92) between the two groups.
  • When limited to infarction and hemorrhage alone, no difference was found between direct and indirect revascularization (P=0.12).

Conclusions:

  • Direct revascularization demonstrated a significant reduction in the combined incidence of all ischemic and hemorrhagic events compared to indirect revascularization.
  • Despite this, no significant differences were found in early postoperative events, long-term infarction/hemorrhage alone, or overall clinical outcomes (mRS).
  • The findings suggest a benefit of direct bypass in reducing the overall burden of cerebrovascular events in ischemic MMD.